EA
Therapeutic Areas
Hytest Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cardiac Markers R&D | Cardiovascular Disease (e.g., Myocardial Infarction) | Commercial |
| Infectious Diseases Reagent Development | Infectious Disease Diagnostics (e.g., HIV, Hepatitis) | Commercial |
| Neuroscience Markers R&D | Neurological Disorders (e.g., Alzheimer's Disease) | Commercial |
| Inflammation Markers R&D | Inflammatory Conditions | Commercial |
| Blood Coagulation & Anemia R&D | Hematological Disorders | Commercial |